JD Supra25d
Avoiding the hindsight trap in the context of a patent obviousness analysis
While courts have often warned that hindsight bias should be avoided when assessing whether a patented invention would have been obvious to the skilled person, the application of this principle ...
ENDPOINTS NEWS26d
Septer­na ends Phase 1 tri­al for hy­poparathy­roidism drug; Sanofi’s Mer­ilog is ap­proved
Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Benzinga.com27d
FDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For Diabetes
Also Read: Sanofi/Johnson & Johnson Partnered Vaccine Against Bacterial Sepsis Flunks Late-Stage Study As a rapid-acting insulin, Merilog helps lower mealtime blood sugar spikes and improve blood ...
Pharm Exec28d
FDA Approves Sanofi’s Rapid Acting Insulin Biosimilar Merilog for Diabetes
The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart), for improving glycemic control in adults and pediatric patients with diabetes mellitus. The regulatory ...
BioSpace28d
Sanofi Challenges Novo With First FDA Nod for NovoLog Biosimilar
In March 2023, Sanofi and Novo came under fire from Sen. Bernie Sanders (I-Vt), who asked the companies to follow in the footsteps of fellow diabetes leader Eli Lilly and lower the price of their ...